Phunware Inc (NASDAQ:PHUN) delivered revenue growth exceeding 120% in the third quarter, while simultaneously expanding the digital platform’s multiscreen-as-a-service (MaaS) backlog to nearly US$8 million.
Net revenues for the quarter ended September 30 2022 totalled $4.8 million, out of which MaaS platform revenues contributed $1.3 million, with hardware revenues of $3.5 million, according to Phunware.
Nextech AR Solutions Corp is experiencing record demand for 3D models in the fourth quarter, and it shows no sign of slowing down in 2023, the company said.
The “3D model mega trend” is gaining traction, Nextech said, and the company has recently closed new 3D modeling deals along with reorders and expanding existing contracts.
OTC Markets Group Inc announced it has finalized the acquisition of EDGAR Online (NASDAQ:EDGR), a premium supplier of real-time SEC regulatory data and financial analytics.
EDGAR Online provides disclosure documents in multiple formats, company financials, structured data sets and mission-critical insights directly to exchanges, brokerage firms, data distributors and financial portals.
American Resources Corporation (NASDAQ:AREC) said its ReElement Technologies division has been awarded a US$200,000, state-level, advanced manufacturing grant from the Indiana Economic Development Corporation for its patented critical battery element purification and separation technology being commercialized in Noblesville, Indiana.
ReElement CCO Chris Moorman said the grant is a great vote of confidence and support from the Indiana Economic Development Corporation, adding that ReElement runs a battery material production train that uses a patented, multi-mode chromatography technology at the Noblesville plant.
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said its near-term focus is on developing intranasal foralumab for inflammatory diseases of the central nervous system (CNS), including non-active secondary-progressive Multiple Sclerosis (SPMS), Alzheimer’s disease and amyotrophic lateral sclerosis.
Tiziana interim CEO Gabriele Cerrone said the biotechnology company is looking forward to leveraging the clinical and pre-clinical results from the promising formulation of intranasal foralumab generated so far in CNS-based autoimmune diseases to guide its pipeline investment.
Copper Fox Metals Inc (TSX-V:CUU, OTCQX:CPFXF). through its wholly-owned subsidiary Desert Fox Copper Inc has updated on recent activities at its 100% owned Van Dyke in-situ copper recovery project.
The Van Dyke project is in the Globe-Miami Mining District in Gila County, Arizona; a Tier 1 mining jurisdiction. The 2020 Preliminary Economic Assessment (PEA) for the project indicated an after-tax net present value of US$644.7 million, and an internal rate of return of 43.4%, based on a 17-year mine life using a US$3.15/lb copper price.
Seeing Machines Limited is a tech unicorn whose current share price belies this status.
That, at least, is the opinion of Cenkos, the corporate broker, which Thursday issued a ‘buy’ note and punchy price target.
Zephyr Energy PLC (AIM:ZPHR, OTCQB:ZPHRF) told investors that its borrowing base has increased as the company continues to progress its assets in America.
The company, in a statement, said its lender North Dakota-based First International Bank and Trust (FIBT) has completed a scheduled semi-annual redetermination of the company's revolving credit facility, resulting in a 30% increase.
Endeavour Mining PLC (LSE:EDV, TSX:EDV, OTCQX:EDVMF) said it is well positioned to hit the top end of full-year targets for production, with costs being kept under control.
The West Africa-focused gold miner produced 343,000 ounces of gold at an all-in-sustaining cost (AISC) of US$960 per oz, stable compared to the preceding quarter despite the impact of the wet season.
88 Energy Ltd (AIM:88E, ASX:88E, OTC:EEENF) told investors it will expand its footprint on Alaska’s North Slope after being named “highest bidder” for 10 leases in the latest Alaskan leasing round.
The leases span some 25,600 contiguous acres immediately south of Prudhoe Bay, the company said in a statement, and it is covered by a suite of 3D seismic data and historic well data that the company has access to.
Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL)’s revenues rose by 21% in the latest quarter as production from its Blanket gold mine hit another new record.
The Zimbabwe-focused miner said production this year is on course to hit the top end of its 73,000-80,000oz guidance after output rose 11% to 21,200oz in the three months to end-September.
Rainbow Rare Earths Ltd (LSE:RBW, OTC:RBWRF) said it allotted 2.0mln new shares at 5.28p per share to the Australian Special Opportunity Fund LP after the fund exercised its final tranche of share options in the rare earths group.
Dealings in the new shares are expected to start on 14 November on the London Stock Exchange’s main market.
Elixir Energy Ltd (ASX:EXR) has booked an initial contingent resource for its 100%-owned asset in Queensland, Australia, newly named the Grandis Gas Project – formerly ATP 2044.
Booked initial contingent resources (2C) are in the order of 395 billion standard cubic feet (BCF) of gas, in addition to its gas resources in Mongolia.
Givex Information Technology Group Limited (TSX:GIVX, OTCQX:GIVXF) said intends to file this week articles of continuance to continue the company out of the Province of British Columbia and into the Province of Ontario and change its name from to Givex Corp. The continuance and name change was overwhelmingly approved by the with an approval rate of 98.3% of the votes cast. There will be no change in the ticker symbol of the company.
Silver Bullet Mines Corp. (TSX-V:SBMI, OTC:SBMCF) has received a cease trade order issued by the Ontario Securities Commission on Nov. 8, 2022, for failing to file its audited annual financial statements and related information for the period ended June 30, 2022. The company's shares will remain suspended until it meets TSX Venture Exchange requirements. Members are prohibited from trading in the securities of the company during the period of the suspension or until further notice.
Victory Resources Corp (CSE:VR, OTC:VRCFF) said it has closed its previously announced non-brokered private placement. The company accepted subscriptions for 7,825,000 units at a price of $0.022 per unit, for gross proceeds of $172,150. Each unit consists of one common share and one warrant exercisable for 2 years at $0.05, subject to the right of the company to accelerate the expiry of the warrants if the stock trades at $0.10 for a period of 10 days. Securities issued on this closing will be subject to a statutory hold period until March 8, 2023. Proceeds will be used for working capital and continued exploration of its properties.
BioVaxys Technology Corp. (CSE:BIOV, OTCQB:BVAXF) said it has completed a non-brokered private placement consisting of 4,050,000 units at a price of $0.10 per unit for total gross proceeds of $405,000. Each unit consists of one common share and one whole warrant exercisable for one share at an exercise price of $0.20 for a period of 48 months. The company also announced that it has settled an aggregate of $150,000 in debt through the issuance of common shares issued at a deemed price of $0.20 per common share.
Vyant Bio (NASDAQ:VYNT) announced that it will be participating at Neuroscience 2022, the 52nd Annual Gathering of the Society for Neuroscience, on November 12th-16th at the San Diego Convention Center. Vyant Bio’s team will deliver two platform presentations in the Rett Syndrome Symposium presenting the identification of a repurposed drug which will be progressed into a patient trial in 2023 to demonstrate its clinical proof of concept for Rett syndrome with a differentiated mechanism of action from the most advanced Rett syndrome clinical candidates. In addition, the Company will present a poster on the discovery of novel targets and therapeutic candidates for CDKL5 deficiency disorder (CDD) in the Stem Cell Models for Neurodevelopmental Disorders session. CDD is one of the most common forms of genetic epilepsy. Full details available here: https://ir.vyantbio.com/news-events/press-releases/detail/1313/vyant-bio-to-participate-at-neuroscience-2022-the-52nd.
Ocean Power Technologies Inc (NYSE-A:OPTT) announced that it will report its fiscal 2023 second quarter for the period ended October 31, 2022 results after the market closes on Wednesday, December 14, 2022.
Lodestar Battery Metals Corp announce that it has changed its name from "Silverton Metals Corp (TSX-V:SVTN, OTCQB:SVTNF)." to "Lodestar Battery Metals Corp." The company's common shares will commence trading on the TSX Venture Exchange under its new stock symbol "LSTR" effective November 14, 2022. Additionally, Lodestar has engaged IR Labs Inc to develop and manage a comprehensive investor relations and corporate communications program, as well as support strategic capital markets advisory services.
RespireRx Pharmaceuticals (OTCQB:RSPI) announced that Jeff Margolis, CFO, is presenting a summary and update about the company at the Investor Summit Q4 sponsored by the Investor Summit Group, in person, on November 14, 2022 from 2:00-2:30pm EST at the Sheraton Times Square, New York, NY. Margolis will be available for in-person one-on-one meetings at the conference location on November 14, 2022. The conference continues on November 15, exclusively virtually and Mr. Margolis will be available for virtual one-on-one meetings that day as well. The public group presentation link is: https://us06web.zoom.us/webinar/register/WN_EI0AHyutSsWzh0vg2LSNJA.
T Stamp Inc (NASDAQ:IDAI, EURONEXT:AIID)("Trust Stamp") announced that Josh Allen, EVP Corporate Finance of Trust Stamp, will be presenting at the Q4 Investor Summit, hosted by the Investor Summit Group, being held on November 14th & 15th at the Sheraton Times Square. Allen will present on November 14 at 2:30 PM ET. A Webcast link is available here: https://us06web.zoom.us/webinar/register/WN_3zPjbE0VReKFQTulHUTTsw.
FSD Pharma Inc (CSE:HUGE, NASDAQ:HUGE) announced that the claim for US$30.2 million brought by the company’s former CEO, Dr. Raza Bokhari, was dismissed yesterday, November 9, 2022. Dr. Bokhari had claimed that he had been wrongfully dismissed. The arbitrator hearing the claim dismissed it in its entirety. The arbitrator also ordered Dr. Bokhari to repay certain monies to FSD Pharma, while also holding Dr. Bokhari responsible for FSD Pharma’s costs of the arbitration. “The outcome of the arbitration represents a full vindication of the actions of the current management and board of directors of FSD Pharma with respect to Dr. Bokhari, prior to, during and subsequent to the 2021 proxy battle. We are happy to report to our shareholders that this claim has been resolved fully in our favour,” said Zeeshan Saeed, Founder, President & Executive Co-Chairman of FSD. Interim CEO Anthony Durkacz added: “We have always believed that Dr. Bokhari’s claims against the Company were without merit. We are pleased to hear that the tribunal has now dealt with the claims. We are looking forward to putting this behind us and focusing our efforts on advancing our drug candidates and creating value for our shareholders.”
BioLargo Inc (OTCQB:BLGO) announced it will host an investor webcast and conference call on Wednesday, November 16, 2022, at 2:00 pm Pacific / 5:00 pm Eastern to review the company's financial results for the three and nine months ended September 30, 2022, discuss recent milestones, and conduct a question-and-answer session. To listen to a live broadcast, go to the site linked below at least 15 minutes prior to the scheduled start time to register and download any necessary audio/video software. To participate in the live webcast and teleconference, use the following details: Webcast Link: https://www.webcaster4.com/Webcast/Page/2448/47095; Teleconference Domestic: 973-528-0011; International: 888-506-0062; Participant Access Code: 796301.
Todos Medical Ltd. (OTCQB:TOMDF) announced that it has terminated the Tollovid products license and distribution agreement it had with T-Cell Protect Hellas S.A. T-Cell Protect has acknowledged the termination and has agreed to remove Todos Medical’s name and logo from its marketing materials, and will remove any reference to Dr. Dorit Arad’s work being associated with T-Cell Protect Hellas S.A. products.
Magna Mining Inc (TSX-V:NICU) announced that it has granted a total of 3,685,000 stock options to purchase common shares of the company to certain directors, officers, employees and consultants pursuant to the company's stock option plan. Such options are exercisable into common shares of the company at an exercise price of $0.47 per common share for a period of three years from the date of grant. The options issued to independent directors vest immediately, while all other options vest 1/3 immediately and 1/3 annually thereafter. All of the options expire on November 10, 2027. In addition, the company has issued a total of 510,000 restricted share units to certain directors, officers and employees of the company in accordance with the company's restricted share unit plan. The RSUs will fully vest on the date that is three year from the date of grant. Once vested, each RSU represents the right to receive one common share of the company or the equivalent cash value thereof, at the company's discretion.